429 research outputs found
Homozygous mutation in the prokineticin-receptor2 gene (Val274Asp) presenting as reversible Kallmann syndrome and persistent oligozoospermia: case report.
Prokineticin 2 (Prok2) or prokineticin-receptor2 (Prok-R2) gene mutations are associated with Kallmann syndrome
(KS). We describe a new homozygous mutation of Prok-R2 gene in a man displaying KS with an apparent reversal of
hypogonadism. The proband, offspring of consanguineous parents, presented at age 19 years with absent puberty, no
sense of smell, low testosterone and gonadotrophin levels. Magnetic resonance imaging showed olfactory bulb absence.
The patient achieved virilization and spermatogenesis with gonadotrophin administration. Two years after discontinuing
hormonal therapy, he maintained moderate oligozoospermia and normal testosterone levels. Prok2 and Prok-
R2 gene sequence analyses were performed. The proband had a homozygous mutation in Prok-R2 exon 2 that harbours
the c.T820>A base substitution, causing the introduction of an aspartic acid in place of valine at position 274
(Val274Asp). His mother had the same mutation in heterozygous state. This report describes a novel homozygous
mutation of Prok-R2 gene in a man with variant KS, underlying the role of Prok-R2 gene in the olfactory and reproductive
system development in humans. Present findings indicate that markedly delayed activation of gonadotrophin
secretion may occur in some KS cases with definite gene defects, and that oligozoospermia might result from a variant
form of reversible hypogonadotrophic hypogonadism
The first Italian COVID-19 lockdown reduced births and voluntary terminations by just under a fifth
No abstract available
Special Issue dedicated to Stefano De Marchi on the occasion of his 60th birthday
As colleagues and friends we dedicate this issue to Stefano De Marchi on the occasion of his 60th birthday, publishing works of some of his collaborators. Stefano has made many important contributions to approximation theory and beyond and is one of the “founding fathers” of this journal. Here we briefly reminisce and recount some of our experiences with Stefano in the spirit of the occasion
Minimally invasive percutaneous treatment for osteoid osteoma of the Spine. A case report
Osteoid osteomas are benign but painful bone-forming tumors usually involving long bones, with localization at the spine in 10-20% of the cases. The most common symptom is back pain responding to nonsteroidal anti-inflammatory drugs, but in some cases, also radicular pain can be present. For years, surgical excision has been considered the best choice of treatment for cases with unresponsive pain and has been practiced with a high percentage of success but also a high rate of fusion with instrumentation. In the last years, percutaneous radiofrequency ablation has been proposed as a new mini-invasive technique for the treatment of osteoid osteomas
Brain Plasticity in Charcot-Marie-Tooth Type 1A Patients? A Combined Structural and Diffusion MRI Study
Central nervous system involvement has been described in peripheral neuropathies, including different forms of Charcot-Marie-Tooth (CMT) disease. The aim of our study was to systematically investigate possible brain structural modifications in CMT1A patients, using volumetric MRI, and diffusion tensor imaging (DTI). In this prospective cross-sectional study, from May 2017 to May 2019, we acquired 3T MRI brain scans of genetically confirmed CMT1A patients and age- and sex-comparable healthy controls. Patients also underwent clinical and electrophysiological examinations assessing motor and sensory domains. Voxel-based morphometry (VBM) and tract-based spatial statistics (TBSS) analyses were performed using a non-parametric approach based on permutations, including age and sex (and total intracranial volume for VBM) as nuisance covariates. When between-group differences emerged at VBM or TBSS analyses, the first eigenvariate was extracted from the cluster and its age- and sex-adjusted standardized residuals tested for correlation with clinical and electrophysiological variables. Twenty CMT1A patients (34.5 ± 11.1 years; M/F:11/9) were enrolled, along with 20 healthy controls (30.1 ± 10.2 years; M/F:11/9). The VBM analysis revealed clusters of significantly increased GM volume in CMT1A patients compared to healthy controls, encompassing the bilateral cerebellar lobules III-VI and the left hippocampus (all ps = 0.04), with no differences in terms of DTI metrics at the TBSS analysis. A negative correlation (r = −0.502, p = 0.03) emerged between ulnar compound motor action potential and the z-scores corresponding to the right cerebellar cluster of augmented GM volume. Our data show evidence of structural reorganization in the brain of CMT1A patients, possibly reflecting neural plasticity mechanisms in response to peripheral nerve pathology and modulating the effect of axonal degeneration on functional impairment
- …